<DOC>
	<DOCNO>NCT01548378</DOCNO>
	<brief_summary>The purpose study evaluate whether intramuscular injection NL003 calf safe effective treatment critical limb ischemia</brief_summary>
	<brief_title>Safety Efficacy Study Using Gene Therapy Critical Limb Ischemia</brief_title>
	<detailed_description>Management CLI process consumes significant amount healthcare resource , new therapeutic approach require . Hepatocyte growth factor ( HGF ) show potent angiogenic growth factor stimulate growth endothelial cell migration vascular smooth muscle cell . Because pluripotent capability , increase availability HGF ischemic tissue achieve therapeutic angiogenesis grow area research . This study use NL003 , DNA plasmid contains novel genomic cDNA hybrid human HGF coding sequence ( HGF-X7 ) express two isoforms HGF , HGF 728 HGF 723 . As currently approve drug reverse CLI patient exhaust surgical endovascular intervention option , induce angiogenesis affect limb NL003 may result increase tissue perfusion , , turn improve wound healing , reduce pain improve limb salvage rate .</detailed_description>
	<mesh_term>Ischemia</mesh_term>
	<mesh_term>Vascular Diseases</mesh_term>
	<mesh_term>Peripheral Vascular Diseases</mesh_term>
	<mesh_term>Peripheral Arterial Disease</mesh_term>
	<mesh_term>Arterial Occlusive Diseases</mesh_term>
	<criteria>Male female , 30 80years age Diagnosis critical limb ischemia ( ASO、TAO、DAO ) ，Rutherford Class 4 5 , include : A rest ankle systolic pressure ≤ 70 mmHg affect limb ; A rest toe systolic pressure ≤ 50 mmHg affect limb ; For patient measurement ankle systolic pressure feasible , TcPO2 ≤ 30mmHg ; Only unilateral affect limb receive treatment。 Significant stenosis ( ≥ 75 % ) one follow artery : superficial femoral , popliteal verify angiography（DSA、CTA、MRA） within 12 month prior enrollment Be willing maintain current drug therapy peripheral arterial disease throughout course study Be willing maintain ulcer treatment Be willing infertility throughout course study If subject childbearing potential , must negative urine pregnancy test result prior study enrollment Tumor screen result clinic meaning，including : Signing informed consent document prior subject study related procedure Subjects undergone successful revascularization procedure sympathectomy within 12 week prior study entry . Acute advance CLI Subjects require amputation target leg within 4 week , significant stenosis ( ≥ 75 % ) Aortoiliac Subjects evidence active infection deep ulceration expose bone tendon extremity plan treatment Heart Failure NYHA classification III IV Stroke、myocardial infarction unstable angina within last 3 month Uncontrolled hypertension define sustain systolic blood pressure ( SBP ) &gt; 180 mmHg diastolic BP ( DBP ) &gt; 110 mmHg Ophthalmologic condition pertinent proliferative retinopathy condition preclude standard ophthalmologic examination Can correctly describe symptom feel Subjects advance liver disease include decompensated cirrhosis , jaundice , ascites bleed varix Subjects currently receive immunosuppressive medication chemotherapy , radiation therapy Positive HIV , active Hepatitis B ( determine HBsAb\ HBcAb\HBsAg ) C infection Specific laboratory value Screening include : Hemoglobin &lt; 8.0 g/dL , WBC &lt; 3,000 cell per microliter , platelet count &lt; 75,000/mm3 , AST and/or ALT &gt; 3 time upper limit normal clinically significant lab abnormality opinion investigator exclusionary Elevated PSA unless prostate cancer exclude Patients recent history ( &lt; 5 year ) new screen find malignant neoplasm except basal cell carcinoma squamous cell carcinoma skin ( excised evidence recurrence ) ; patient family history colon cancer first degree relative exclude unless undergone colonoscopy last 12 month negative finding Subjects require &gt; 100 mg daily acetylsalicylic acid , COX2 inhibitor drug ( ) high dose steroid ( except inhale steroid ) Subjects co morbid condition likely interfere assessment safety efficacy estimate life expectancy le 12 month History drug alcohol abuse / dependence past 12 month Use investigational drug treatment past 3 month</criteria>
	<gender>All</gender>
	<minimum_age>30 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>March 2015</verification_date>
	<keyword>HGF</keyword>
	<keyword>Gene</keyword>
	<keyword>Critical Limb Ischemia</keyword>
</DOC>